News for Taiwan Liposome Company, Ltd. (TLC)

Growing prevalence of visual impairment propels technological advances in ocular drug delivery...

Nanomedicine is experiencing heightened demand, mainly propelled by the increasing occurrence of chronic ailments like cardiovascular, neurological,...

Digital therapeutics present a prospect to diminish healthcare costs through the facilitation of remote and effective healthcare delivery, mitigating the...

/PRNewswire/ -- The "Ocular Drug Delivery Devices Market: Global Market Size, Forecast, Insights, and Competitive Landscape" report has been added to...

The Global Ocular Drug Delivery System Market Size was valued at USD 69.1 Billion in 2022 and the Worldwide Ocular Drug Delivery System Market Size is...

Ocular Drug Delivery Market Size By Technology (Nano-Particle Drug Delivery Systems, Implantable Ocular Drug Delivery Systems, and Particulate Drug...

The prevalence of Knee Osteoarthritis has been rising since the past few years, which prompts the growing demand for the treatment options. The market is...

/PRNewswire/ -- The "Global Targeted Drug Delivery Market by Disease Type, Application, End-user, and Region - Size, Share, Outlook, and Opportunity Analysis,...

Here's what you need to know about trading penny stocks on June 15th

/PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that its subsidiary Endo Ventures Limited (EVL) has executed an agreement with Taiwan...

DUBLIN, July 29, 2021 /PRNewswire/ -- The